Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

G. Bone, Henry; A. Bolognese, Michael; Kin Yuen, Chui; L. Kendler, David; D. Miller, Paul; Yang, YuChing; Grazette, Luanda; San Martín, Javier; C. Gallagher, John

doi:10.1210/jc.2010-1502

Public

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Published in The Journal of Clinical Endocrinology & Metabolism • Feb 3, 2011

Authors:

Henry G. Bone

Michael A. Bolognese

Chui Kin Yuen

Abstract

CONTEXT: Denosumab treatment for 24 months increased bone mineral density (BMD) and reduced bone turnover markers (BTM) in postmenopausal women. OBJECTIVE: The aim was to determine the effects of prior denosumab or placebo injections on BMD, BTM, and safety over 24 months after treatment discontinua...

Subject

N-terminal telopeptide

Medicine

Denosumab

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!